Nutanix Files 8-K for Regulation FD Disclosure

Ticker: NTNX · Form: 8-K · Filed: Dec 10, 2024 · CIK: 1618732

Nutanix, INC. 8-K Filing Summary
FieldDetail
CompanyNutanix, INC. (NTNX)
Form Type8-K
Filed DateDec 10, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.000025, $500 million
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, disclosure

Related Tickers: NTNX

TL;DR

Nutanix filed an 8-K for a Reg FD disclosure on Dec 10, 2024.

AI Summary

On December 10, 2024, Nutanix, Inc. filed an 8-K report. The filing indicates that the company is providing a Regulation FD Disclosure. No specific financial figures or material events beyond this disclosure type are detailed in the provided text.

Why It Matters

This filing signals an official communication from Nutanix to the public regarding regulatory disclosure requirements, ensuring transparency for investors.

Risk Assessment

Risk Level: low — The filing is a standard regulatory disclosure and does not contain information about significant financial changes, legal issues, or operational disruptions.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Nutanix, Inc.?

The primary purpose of this 8-K filing is to provide a Regulation FD Disclosure.

On what date was this 8-K report filed?

This 8-K report was filed on December 10, 2024.

What is the exact name of the registrant as specified in its charter?

The exact name of the registrant is Nutanix, Inc.

In which jurisdiction was Nutanix, Inc. incorporated?

Nutanix, Inc. was incorporated in Delaware.

What is the principal executive office address for Nutanix, Inc.?

The address of the principal executive offices is 1740 Technology Drive, Suite 150, San Jose, California 95110.

Filing Stats: 586 words · 2 min read · ~2 pages · Grade level 14.8 · Accepted 2024-12-10 16:43:53

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NUTANIX, INC. Date: December 10, 2024 By: /s/ Rukmini Sivaraman Rukmini Sivaraman Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing